Rheumatology teams care for patients with diverse, systemic autoimmune diseases who are often immunosuppressed and at high risk of infections. The current COVID-19 pandemic has presented particular challenges in caring for and managing this patient group. The office of the chief medical officer (CMO) for England contacted the rheumatology community to provide expert advice on the identification of extremely vulnerable patients at very high risk during the COVID-19 pandemic who should be 'shielded'. This involves the patients being asked to strictly self-isolate for at least 12 weeks with additional funded support provided for them to remain at home. A group of rheumatologists (the authors) have devised a pragmatic guide to identifying the very highest risk group using a rapidly developed scoring system which went live simultaneous with the Government announcement on shielding and was cascaded to all rheumatologists working in England.
Keywords: COVID-19; SARS-CoV-2; health economics; innovation; testing.
© Royal College of Physicians 2020. All rights reserved.
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.Clin Med (Lond). 2020 May 1:clinmed.2020-0160. doi: 10.7861/clinmed.2020-0160. Online ahead of print. Clin Med (Lond). 2020. PMID: 32357977
What Does the COVID-19 Pandemic Mean for Rheumatology Patients?Curr Treatm Opt Rheumatol. 2020 Apr 30:1-4. doi: 10.1007/s40674-020-00145-y. Online ahead of print. Curr Treatm Opt Rheumatol. 2020. PMID: 32355607 Free PMC article. Review.
Reducing SARS-CoV-2 transmission in the UK: A behavioural science approach to identifying options for increasing adherence to social distancing and shielding vulnerable people.Br J Health Psychol. 2020 May 19. doi: 10.1111/bjhp.12428. Online ahead of print. Br J Health Psychol. 2020. PMID: 32428385
American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID-19 Pandemic.Arthritis Rheumatol. 2020 Apr 29. doi: 10.1002/art.41301. Online ahead of print. Arthritis Rheumatol. 2020. PMID: 32349183
COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.Version 2. Pediatr Rheumatol Online J. 2020 Apr 22;18(1):35. doi: 10.1186/s12969-020-00422-z. Pediatr Rheumatol Online J. 2020. PMID: 32321540 Free PMC article. Review.